GPT and metabolic dysfunction-associated steatotic liver disease: These outcomes are in accordance with previous studies that evidenced significant increases in the specific liver enzymes (ALT, GGT, and AST/ALT ratio <1) and in Hb1Ac in NAFLD subjects as compared to healthy subjects [36,37,38].